Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend (12mg)

Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend (12mg)

Product Description

Tesamorelin & CJC-1295 (Mod GRF 1-29) & Ipamorelin Blend (12mg) is a premium research peptide formulation designed for laboratory and analytical applications. This advanced blend combines three well-known synthetic peptides in a single vial: Tesamorelin (6mg), CJC-1295 No DAC (Mod GRF 1-29) (3mg), and Ipamorelin (3mg).

Tesamorelin is a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), while CJC-1295 (Mod GRF 1-29) is a modified GHRH fragment developed to enhance stability and support pulsatile growth hormone signaling. Ipamorelin is a selective growth hormone secretagogue that has been extensively studied for its interaction with ghrelin receptors. Together, these peptides provide researchers with an opportunity to investigate multiple pathways involved in growth hormone regulation and endocrine function.

Each vial contains lyophilized powder manufactured to high purity standards, making it suitable for in-vitro, laboratory, and scientific research purposes only. This product is not intended for human consumption, therapeutic use, diagnosis, treatment, or prevention of any disease.